Shares of Gilead Sciences GILD are lower on the session by 0.85%, trading at $40.65.
Overall call volume is now running at 4.43x the daily average, with 9% of all calls traded being purchases on the offer. 19,059 contracts have traded on the session so far.
Gilead Sciences, Inc. is a biopharmaceutical company. The company focuses on the development and commercialization of human therapeutics for life threatening diseases.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in